Green Pass mandatory, but tampons are not enough for all workers
Starting today, Friday 15 October 2021, the Green Pass becomes mandatory for employees, public and private, but the risk is that there are not enough tampons for all workers.
The Green Pass requirement involves approx 23 millioni of workers, divided as follows: 14.6 millions of employees of private companies, 3.2 millions of public employees e 4.9 millions of self-employed.
According to government estimates they would be approx 2.5 million workers to date without green certification. The data, however, do not take into account the self-employed.
There Gimbe Foundation, on the other hand, calculates in almost 4 million3.8 to be exact, the number of unvaccinated workers for whom a swab is needed in order to obtain the Green Pass.
In fact, if you are not vaccinated, green certification can be obtained either if you are cured of Covid within six months or through a negative antigen or molecular test, which is valid for 48 hours from the moment it is carried out.
It is highly probable, therefore, that most of those 4 million workers without Green Pass will resort to rapid tests with a request that could reach, again according to data provided by Gimbe, among the 8 and 11 million weekly tampons, more than 1 million a day.
Is Italy able to carry out such a large number of swabs per day? The answer is no, at least according to the numbers recorded so far.
In our country, in fact, they are carried out on average about 300 thousand tampons a day, both molecular and unsanitary, while in the week 6-12 October, according to Gimbe, were made 1.2 million tests quick unsanitary, or what should be done in one day starting from 15 October onwards.
Furthermore, two thirds of unsanitary rapid swabs are carried out in pharmacies and, according to Gimbe President Nino Cartabellotta, the current system “will not be able to guarantee, at least in the short term, an adequate supply of antigenic products at a controlled price”.
According to Cartabellotta, in order to cope with the increase in the need for tests, “it is urgent to expand the number of pharmacies and other authorized structures that adhere to the controlled price agreement, and to strengthen the activity to increase the number of swabs”.
A position also shared by the vice president of ADF, the association of pharmaceutical distributors, Alessandro Albertini, according to whom the diagnostic capacity of pharmacies, especially the smallest ones, could be put to the test not so much for the supply of tests, but rather for the personnel who will have to carry them out, which may prove insufficient to meet all organizational needs.